Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Innovent Announces Primary Endpoint Met in Phase 2 of IBI302 in Neovascular AMD Treatment
Details : AVA1014 (ferric citrate coordination complex) is an iron containing phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis.
Product Name : AVA1014
Product Type : Small molecule
Upfront Cash : Not Applicable
April 23, 2024
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : The COMPASS trial was designed to investigate the efficacy and safety of dosing ferric citrate twice-daily as compared to the current U.S. FDA approved dosing of ferric citrate three times daily in adult patients with chronic kidney disease (CKD) not on ...
Product Name : Auryxia
Product Type : Small molecule
Upfront Cash : Not Applicable
June 10, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : The NDA is based on JT and Torii's Phase 3 clinical study and other clinical studies in adult patients with IDA in Japan.
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Not Applicable
May 18, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable